November 2007 | Oncology & Biotech News

June 29, 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

June 29, 2010

New data recently published in the Journal of Clinical Oncology has provided a degree of hopeful news to oncologists and their patients, suggesting that progress is being made in the fight against cancer and that a number of trends are pointing toward continued gains.

June 29, 2010

News articles featured in this issue include: 1) Off-Label Use of Oncology Medications 2) More Work to Do on Breast Cancer Guideline Adoption 3) Multiple Biopsies Are Needed to Diagnose Prostate Cancer, and more

June 29, 2010

Physicians' Financial News focuses on newsmaking and/or notable companies in the oncology/biotech sector. In this issue: 1) Pharmion: Oncology-Centered Focus Fuels Continued Pharmion Growth 2) Bristol-Myers Squibb: Treatment-Resistant Breast Cancer Targeted 3) Merger-Mania Poised to Envelop Biotech Sector? and more

June 29, 2010

The European Commission has granted marketing authorization to sorafenib (Nexavar) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer.

June 29, 2010

Blood clots and their complications are a major cause of death in cancer patients, and affect up to 20% of persons with cancer at some point in their treatment.

June 29, 2010

The Clinical Trials Reported in this issue include: PHASE III: 1) Trastuzumab and Anastrozole Extend Breast Cancer Survival in Patients Who Received Anastrozole Alone Earlier PHASE II: 1) Motexafin for Non%u2013Small Cell Lung Cancer 2) Oral Satraplatin Monotherapy for the Treatment of Metastatic Breast Cancer Shows Little Response, and more

June 29, 2010

Articles in this issue include: 1) Italy: Is the Knee Bone Connected to the Lung? 2) Turkey: Gabapentin Helps Opioid Treatment Alleviate Neuropathic Pain 3) China: Is a Blood Test for Early Diagnosis of Liver Cancer Within Reach?, and more

June 25, 2010

The 14th annual European Cancer Conference, sponsored by the European Cancer Organisation (ECCO), was held September 23-27 in Barcelona, Spain. The results of numerous major clinical trials were presented, along with an increasing wealth of new preclinical and translational data.

June 25, 2010

In this issue, we present updates from the 14th European Cancer Conference (ECCO), which took place September 23-27 in Barcelona, Spain. This year's meeting provided one of the largest multidisciplinary forums for discussing the entire spectrum of cancer research and management.